Literature DB >> 929035

[Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].

A Buge, G Rancurel, H Dechy.   

Abstract

Acute myoclonic encephalopathy related to the ingestion of bismuth salts has been known for 3 years and would appear to be reversible. Of a total of 41 cases, 32 were observed for an average of more than a year. Alongside the commoner benign forms, there coexist severe forms, sometimes fatal, prolonged forms and complicated forms. Permanent deterioration, affecting memory above all, tremor, marked insomnia, headache and disturbed gait are amongst the most durable complications, sometimes definitive, whilst in four cases osteo-arthropathy of the shoulders was associated with permanent invalidism.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 929035

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  6 in total

1.  [Monoamine metabolites and cyclic nucleotides in the cerebrospinal fluid of patients with bismuth or mercury poisoning].

Authors:  H Cramer; B Renaud; M Billiard; J Mouret; R Hammers
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

Review 2.  Toxic substances and the nervous system: the role of clinical observation.

Authors:  P M Le Quesne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

Review 3.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 4.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

6.  Epileptic phenomena in bismuth toxic encephalopathy.

Authors:  A Buge; V Supino-Viterbo; G Rancurel; C Pontes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.